Neuroendocrine carcinomas
Clinical trials for Neuroendocrine carcinomas explained in plain language.
Never miss a new study
Get alerted when new Neuroendocrine carcinomas trials appear
Sign up with your email to follow new studies for Neuroendocrine carcinomas, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets Hard-to-Treat lung cancer in early trial
Disease control Recruiting nowThis study tests a new drug called IDE849, alone or with other drugs, in people with cancers that have a protein called DLL3, including small cell lung cancer. The trial has two phases and aims to see if the drug is safe and shrinks tumors. About 208 participants who have already…
Matched conditions: NEUROENDOCRINE CARCINOMAS
Phase 1/2 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New hope for rare cancers: experimental drug ADCT-701 enters human trials
Disease control Recruiting nowThis early-phase trial tests a new drug called ADCT-701 in adults with rare cancers like neuroendocrine tumors, adrenal cancer, and malignant peripheral nerve sheath tumors. The goal is to find the safest dose and see if it can shrink tumors or slow disease. Participants receive …
Matched conditions: NEUROENDOCRINE CARCINOMAS
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study maps cancer treatment journeys across latin america
Knowledge-focused Recruiting nowThis study looks back at medical records of 200 adults in Latin America with a rare and aggressive cancer called neuroendocrine carcinoma. Researchers want to understand how patients are diagnosed, what treatments they receive, and how their disease progresses over time. The goal…
Matched conditions: NEUROENDOCRINE CARCINOMAS
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC